Related Experiment Video
Updated: Jun 26, 2026

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
Correlation between gut microbiota and tumor immune microenvironment: A bibliometric and visualized study
Zheng-Jun Hu1, Hui-Rong Zhu2, Yong-Jie Jin1
1Department of Oncology, Shanghai Jiading District Hospital of Traditional Chinese Medicine, Shanghai 200000, China.
This bibliometric analysis reveals a surge in gut microbiota and tumor immune microenvironment (TIME) research since 2019. China leads publications, while the US shows the most influence, with immunotherapy emerging as a key research focus.
Area of Science:
- Investigates the intersection of microbiology, immunology, and oncology.
- Utilizes bibliometric analysis to map the scientific landscape of gut microbiota and the tumor immune microenvironment (TIME).
Background:
- Growing evidence links gut microbiota composition to the tumor immune microenvironment (TIME).
- A systematic bibliometric study was lacking to comprehensively assess this research area.
Purpose of the Study:
- To provide a bibliometric overview of global research on gut microbiota and TIME.
- To identify leading countries, institutions, researchers, and emerging research themes in this field.
Main Methods:
- Bibliometric analysis of 491 publications from Web of Science Core Collection (2014-2024).
- Utilized CiteSpace, VOSviewer, and R for data visualization and analysis of countries, institutions, authors, and keywords.
Main Results:
- Publication numbers rapidly increased from 2019 onwards.
- China and the United States are the most prolific countries; the US exhibits the highest influence.
- Key research hotspots include 'gut microbiota,' 'tumor microenvironment,' and 'immunotherapy.'
Conclusions:
- The field of gut microbiota and TIME research has expanded significantly over the past decade.
- Future research should focus on specific gut microbes, their metabolites, and their impact on immune cells and immunotherapy efficacy.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Tumor Immunotherapy

